Anzeige
Mehr »
Dienstag, 13.05.2025 - Börsentäglich über 12.000 News
Wenn Rendite auf Sicherheit trifft: Warum Almonty Industries plötzlich jeder will!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1XDTV | ISIN: NL0010696654 | Ticker-Symbol: UQ1
Tradegate
13.05.25 | 18:18
11,400 Euro
-3,88 % -0,460
1-Jahres-Chart
UNIQURE NV Chart 1 Jahr
5-Tage-Chart
UNIQURE NV 5-Tage-Chart
RealtimeGeldBriefZeit
11,43011,61522:23
11,28011,62522:00

Aktuelle News zur UNIQURE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
UNIQURE Aktie jetzt für 0€ handeln
FruniQure N.V. - 10-Q, Quarterly Report1
FruniQure GAAP EPS of -$0.82 beats by $0.18, revenue of $1.57M misses by $5.14M3
FruniQure N.V. - 8-K, Current Report2
FruniQure Inc.: uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress192~ AMT-130 granted Breakthrough Therapy designation by FDA ~ ~ Initial safety data from third cohort of Phase I/II study show AMT-130 continues to be generally well-tolerated, with no treatment-related...
► Artikel lesen
DoEarnings Outlook For uniQure1
05.05.uniQure Inc.: uniQure to Announce First Quarter 2025 Financial Results361~ uniQure to host inaugural earnings call on Friday, May 9, 2025 at 8:30 a.m. ET ~LEXINGTON, Mass. and AMSTERDAM, the Netherlands, May 05, 2025N.V. (NASDAQ: QURE), a leading gene therapy company advancing...
► Artikel lesen
22.04.UniQure stock holds $70 target, buoyed by FDA breakthrough nod12
21.04.FDA grants breakthrough status to uniQure's Huntington's disease therapy5
17.04.uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday6
17.04.Why Is Gene Therapy Developer uniQure Stock Trading Higher On Thursday?3
17.04.uniQure jumps on FDA breakthrough tag for Huntington's disease drug2
17.04.HotStocks USA: +45 % bei uniQure2
17.04.uniQure-Aktien steigen nach FDA-Durchbruchtherapie-Status23
17.04.uniQure shares soar on FDA breakthrough therapy designation1
17.04.uniQure Inc.: uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington's Disease767~ Breakthrough Therapy designation based on clinical evidence from Phase I/II trials showing meaningful slowing of disease progression ~ ~ Additional regulatory update and guidance on the Biologics...
► Artikel lesen
16.04.uniQure N.V. - 8-K, Current Report1
01.04.Chardan sets uniQure stock Buy rating, $38 target on gene therapy potential-
27.02.uniQure GAAP EPS of -$4.92 misses by $0.97, revenue of $27.1M misses by $12.3M5
27.02.uniQure N.V. - 10-K, Annual Report-
27.02.uniQure Inc.: uniQure Announces 2024 Financial Results and Highlights Recent Company Progress539~ Announced alignment with the U.S. Food and Drug Administration (FDA) on key elements of the Accelerated Approval pathway for AMT-130 in Huntington's disease; Initiated preparations for a potential...
► Artikel lesen
Seite:  Weiter >>
55 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1